Chemotherapy-induced Peripheral Neuropathy According to Biopsychosocial Model: A Descriptive Cross-Sectional Correlational Study

Abstract

Purpose The present study aimed to assess the biological health, perceived well-being and social well-being of cancer patients with CIPN within the scope of the biopsychosocial model. MethodsThis study was conducted in oncology clinics and outpatient clinics of a research hospital. The sample comprised 109 patients who met the following inclusion criteria: age ≥ 18 years, completed at least three cycles of taxane and platinum chemotherapy treatment, showed peripheral neuropathy symptoms, could communicate in Turkish and provided consent to participate in the study. For data collection, Patient Information Form, Chemotherapy-induced Peripheral Neuropathy Scale (EQRTC QLQ CIPN20), Perceived Well-being Scale and Social Well-being Scale were used. Results The EQRTC QLQ CIPN20 score was higher in those with high school and higher education than in those with primary school education and below. Perceived well-being was higher with the increase in age, in males, patients receiving only chemotherapy but no immunotherapy, patients without additional stressors, unemployed patients, patients receiving care support from their spouses at home and patients living with their spouses. The social well-being level was higher in those with higher age and number of treatments, those without stem cell transplantation, those without additional stressors, those with primary school education and below and those living alone. Conclusions These findings suggest that CIPN symptoms should be evaluated holistically and supportive care interventions should be developed for these patients.